目的：观察急诊冠脉介入治疗(pci)的疗效及安全性。
Objective: To evaluate the clinical efficiency and safety of emergency percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) patients.
目的探讨经桡动脉途径行冠脉介入治疗的临床疗效及安全性。
Objective: To evaluate results and safety of coronary intervention therapy through radial artery.
目前，冠脉介入治疗在绝大多数介入治疗中心仍是以股动脉为主要途径。
Current, coronal arteries and veins intervenes cure is in center of great majority intervening treatment still is it is main avenue with arteria femoralis.
方法回顾性分析3例经桡动脉冠脉介入治疗术后外周血管并发症护理过程。
Methods Retrospectively analyzed the nursing process of 3 cases of peripheral vascular complications after transradial coronary intervention.
目的探讨急性心肌梗死直接经皮冠脉介入治疗（PCI）的疗效，方法及安全性。
To investigate the effect, method and safety of direct percutaneous coronary intervention (PCI) for the treatment of acute myocardial infarction.
目的探讨65岁以上急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(pci)的临床疗效。
Objectives To explore the clinical effects of percutaneous coronary interventions (PCI) on elderly patients with acute coronary syndrome (ACS) who were all more than 65 years old.
目的：本研究旨在探索阿托伐他汀对急性冠脉综合征(ACS)患者行经皮冠脉介入治疗(pci)潜在的保护作用。
Objectives: This study sought to investigate potential protective effects of atorvastatin in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI).
氯吡格雷是一种抗血小板药物，是新型二磷酸腺苷受体拮抗剂，已广泛应用于急性冠脉综合征和经皮冠状动脉介入治疗的抗血栓治疗。
Clopidogrel is a kind of drug to resistant platelet, it is a new ADP receptor resistant. It has been used in acute coronary syndrome and percutaneous coronary intervention patients widely.
目的探讨临床护理路径在复杂冠脉病变患者介入治疗中的应用效果。
Objective To evaluate the effect of different clinical nursing pathways in interventional therapy for complex coronary lesions.
目的： 长期以来，介入治疗在非ST段抬高的急性冠脉综合症（ACS）患者的价值方面，意见不一。
Objective There have been many controversies on the value of percutaneous coronary intervention (PCI) in patients of non-ST-segment elevation ACS.
所有的病人在经皮冠脉介入手术前、术中、术后都进行标准的医学治疗。
All patients also received standard medical therapy before, during, and after the procedure.
事实上，采用冠脉血流储备指导介入治疗在哪里安置支架的研究非常有限。
There are very limited studies that actually use FFR to actually guide the intervention as to where to place the stent.
早期临床试验表明常规介入治疗可改善ST段抬高型急冠脉综合征病人预后。
Background Earlier trials have shown that a routine invasive strategy improves outcomes in patients with acute coronary syndromes without ST-segment elevation.
讨论PTCA的优点及初步开展介入性冠脉治疗应用CASI的经验。
The paper discusses the advantages of PTCA and experience of application in CASI.
在中国，超过80%急性冠脉综合征的患者介入治疗过程中选择des，您如何看待？
You know, in China, there are more than 80% ACS patients implanted with DES if they are performed PCI. What do you think about it?
双侧冠脉造影组患者的介入治疗成功率优于单侧冠脉造影组。
Coronary angiography in patients with bilateral involvement of the treatment success rate of coronary angiography is superior to unilateral group.
结论MSCT冠状动脉成像能较好的评价冠状动脉病变血管的狭窄程度以及斑块的性质，并可作为冠脉病变介入治疗的筛选。
Conclusion the degree of angiostenosis and the character of plaque can be evaluated by MSCT coronary artery imaging, and it may be a way to...
结论MSCT冠状动脉成像能较好的评价冠状动脉病变血管的狭窄程度以及斑块的性质，并可作为冠脉病变介入治疗的筛选。
Conclusion the degree of angiostenosis and the character of plaque can be evaluated by MSCT coronary artery imaging, and it may be a way to...
应用推荐